25 Stocks Moving In Thursday's Pre-Market Session

Gainers

• Halozyme Therapeutics, Inc. HALO rose 47.3 percent to $15.75 in pre-market trading after the company disclosed that its Phase 2 study in advanced pancreas cancer achieved key endpoints.
• CTI BioPharma Corp CTIC rose 20.7 percent to $4.79 in pre-market trading after the company reported the removal of full clinical hold on pacritinib.
• CEB Inc. CEB shares rose 16.4 percent to $72.05 in pre-market trading after Gartner Inc IT announced plans to acquire the company for $2.6 billion in cash and stock.
• EnteroMedics Inc ETRM rose 16.3 percent to $2.43 in pre-market trading after surging 11.17 percent on Wednesday. EnteroMedics disclosed that its vBloc® Neurometabolic Therapy is now available at MedStar Health in Maryland and Roper St. Francis in South Carolina.
• Genocea Biosciences Inc GNCA shares rose 15.6 percent to $5.25 in pre-market trading after announcing positive 6-month results from GEN-003 Phase 2b clinical trial.
• Evoke Pharma Inc EVOK shares rose 14.9 percent to $3.09 in pre-market trading after climbing 29.95 percent on Wednesday. Rodman & Renshaw upgraded Evoke Pharma from Neutral to Buy.
• Cesca Therapeutics Inc KOOL rose 13.6 percent to $4.17 in pre-market trading after the company reported the FDA approval for its IDE supplement for Phase III clinical trial.
• Tidewater Inc. TDW rose 11.1 percent to $4.20 in pre-market trading after gaining 4.71 percent on Wednesday.
• Sears Holdings Corp SHLD shares rose 7.6 percent to $11.15 in pre-market trading. Stanley Black & Decker SWK agreed to buy the Craftsman brand from Sears for around $900 million.
• VirnetX Holding Corporation VHC shares rose 5.8 percent to $2.75 in pre-market trading after surging 18.18 percent on Wednesday.
• Sangamo Biosciences, Inc. SGMO rose 5.7 percent to $3.70 in pre-market trading after the company disclosed that it has received the FDA clearance of investigational New Drug Application for its SB-525 gene therapy program for hemophilia A.
• Alexion Pharmaceuticals, Inc. ALXN shares rose 5.1 percent to $133.55 in pre-market trading. Alexion filed its delayed report for the third quarter and affirmed its FY16 guidance. The Audit and Finance Committee concluded there is no need to restate financials based on the investigation.
• China Life Insurance Company Ltd. (ADR) LFC rose 5 percent to $13.99 in pre-market trading after gaining 0.23 percent on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• AEterna Zentaris Inc. (USA) AEZS shares fell 35.6 percent to $2.35 in pre-market trading after the company disclosed that Macrilen failed to achieve its objective in Phase 3 trial. The company is evaluating whether it will continue development of Macrilen.
• Kohl's Corporation KSS fell 15.3 percent to $43.94 in pre-market trading after the company lowered its earnings forecast for fiscal 2016.
• Heron Therapeutics Inc HRTX shares fell around 11.6 percent to $12.20 in pre-market trading. Heron Therapeutics reported topline results from Phase 2 clinical trial of HTX-011 in abdominoplasty. The company also reported synergy of bupivacaine and meloxicam with HTX-011 for the prevention of post-operative pain in Phase 2 clinical studies.
• Macy's Inc M fell 10.3 percent to $32.16 in pre-market trading after the company announced plans to close 68 stores and reduced its FY16 earnings guidance.
• Travelers Companies Inc TRV fell 8.8 percent to $109.65 in pre-market trading. Morgan Stanley downgraded Travelers from Equal-Weight to Underweight.
• Helix Energy Solutions Group Inc HLX shares fell around 7.1 percent to $9.00 in pre-market trading. Helix Energy Solutions priced its upsized 23 million share offering at $8.65 per share.
• KNOT Offshore Partners LP KNOP shares fell 5.6 percent to $22.85 in pre-market trading. KNOT Offshore Partners reported an offering of 2,500,000 common units.
• J C Penney Company Inc JCP shares fell 5.6 percent to $8.00 in pre-market trading after rising 1.68 percent on Wednesday.
• Nordstrom, Inc. JWN shares fell 5.4 percent to $46.26 in the pre-market trading session after rising 2.73 percent on Wednesday.
• L Brands Inc LB fell 4.4 percent to $64.35 in pre-market trading. L Brands reported a 1 percent gain in its net sales for December. The company expects Q4 EPS to be toward lower end of its $1.85-$2.00 guidance.
• Kilroy Realty Corp KRC fell around 2.2 percent to $72.65 in pre-market trading. Kilroy Realty reported an offering of 3.5 million shares of common stock.
• Loxo Oncology Inc LOXO shares fell 2.1 percent to $32.00 in pre-market trading. Loxo Oncology priced its 3.87 million share offering at $31 per share.